NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
NextCure has raised $21.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
NextCure's investors include Eli Lilly, Hillhouse Investment, Pfizer, Lilly Asia Ventures, Canaan Partners.
NextCure is headquartered in Beltsville, United States.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
NextCure is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NextCure — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/nextcure. Accessed September 13, 2026.
VCBacked. (2025). NextCure — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/nextcure
{{cite web |title=NextCure — Funding & Investors |url=https://www.vcbacked.co/company/nextcure |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated